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Methods: The mouse femoral artery wire injury model was performed
in 10-week-old male C57BL/6 mice. Treatment groups included control,
injury, and injuryNO (n 5/group). Arteries were harvested at 24 hours,
3 days, 7 days, and 2 weeks after injury and assessed for Sca1 cells using
immunofluorescence. Sca1 staining was graded on a scale of 0 to 4 for the
intima, media, and adventitia in four high-power fields per section.
Results: Sca1 staining in the adventitia after injury significantly
decreased at 24 hours (1.9  0.13, P  .001) and 3 days (1.9  0.12, P 
.001) and returned to baseline by 2 weeks. Sca1 staining in the media after
injury significantly increased by 7 days (2.3 0.23), and persisted to 2 weeks
(2.4 0.19) after injury (P .001). Sca1 staining in the intima after injury
also significantly increased by 7 days (3.0  0.14) and persisted to 2 weeks
(2.7 0.14) after injury (P .001). In the adventitia, NOhad no significant
effect on Sca1 levels. However in the media, NO significantly decreased
Sca1 levels at 7 days (1.5 0.19) vs injury alone (P .002). In the intima,
NO significantly decreased Sca1 levels at 7 days (2.2  0.23) and 2 weeks
(2.3  0.18) vs. injury alone (P  .001 and P  .03, respectively).
Conclusions: The level of resident Sca1 stem cells decreases in the
adventitia after arterial injury and then increases in the media and neointima,
suggesting that Sca1 stem cells contribute to the formation of neointimal
hyperplasia. NO decreases Sca1 levels in the intima and media after injury,
suggesting one mechanism by which NO may inhibit the formation of
neointimal hyperplasia. Together, these data suggest an important role of
Sca1 stem cells in the arterial injury process. Identification of the mecha-
nism of Sca1 inhibition by NO could lead to a therapy to prevent neoin-
timal hyperplasia.
Patients With Chronic Obstructive Pulmonary Disease Have Shorter
Survival but Superior Endovascular Outcomes After Endovascular
Aneurysm Repair
Moqueet A. Qureshi, MD, Roy K. Greenberg, MD, Tara M. Mastracci,
MD, Matthew J. Eagleton, MD, and Adrian V. Hernandez, PhD. Vascular
Surgery/Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
Objectives: This study was conducted to determine the effect of
pulmonary disease on outcomes after endovascular abdominal (EVAR) and
thoracoabdominal (eTAAA) aneurysm repair.
Methods: A prospective study of high-risk patients undergoing EVAR
and eTAAA repair between 1998 and 2009 was used to contrast clinical and
endovascular outcomes between chronic obstructive pulmonary disease
(COPD; group 1) and non-COPD patients (group 2). COPD patients were
classified in accordance with the severity of their pulmonary disease using the
criteria. Survival, morphologic changes, and complications were assessed
using Cox models and life-table analyses. The cause and timing of deaths
between the groups was compared.
Results:A total of 905 patients were analyzed, of which 289 (32%) had
COPD. EVAR was performed in 334 patients (37%), whereas fenestrated/
branched devices were used in the remaining 571 (63%). Group 1 patients
were younger (73.5  6.7 vs 75.6  8.2 years), had a better glomerular
filtration rate (67.8  25.8 vs 61.0  23.3 mL/min/1.73 m2), had higher
hematocrits (41.6 5.0 vs 40.5 4.6), and had more extensive aneurysms.
Mean follow-up was 39.5  30.9 months. Early (3% vs 3%) and late (2% vs
1%) aneurysm-related deaths were similar between the two groups. Survival
in group 1 was lower than that in group 2 (P .0001; Fig 1). Furthermore,
survival in group 1 was dependent upon the severity of disease, with Global
Initiative for Chronic Obstructive LungDisease classification I and II similar
to group 2, and classifications III and IV demonstrating lower survival rates
(P  .0001; Fig 2). Relevant pulmonary function test variables included a
lower forced expiratory volume in 1 second and forced expiratory flow
25%-75%, which were associated with decreased survival. Surrogate endo-
vascular outcome analyses demonstrated that group 1 patients had fewer
endoleaks (20% vs 25%, P  .05) and more rapid sac shrinkage rate (1.66
mm/y difference, P  .001).
Conclusions: The perioperative risk of mortality between COPD and
non-COPD patients is eliminated when endovascular techniques are used.
Long-term survival in COPD patients is most strongly related to the severity
of their disease, and forced expiratory volume in 1 second and forced
expiratory flow 25%-75%, are reasonable indicators of poor long term
outcomes. Morphologic changes following EVAR and eTAAA repair are
more favorable in COPD patients, with a lower endoleak rate and faster sac
shrinkage.
Are Lower Extremity Endovascular Procedures Associated with Fewer
Hospital Readmissions?
ToddR.Vogel,MD,Robin L. Kruse, PhD, andW.KirtNichols,MD. University
ofMissouri Hospitals and Clinics, Columbia, Mo
Objectives: As pressure to contain health care costs increases, there has
been greater scrutiny of readmissions in the vascular surgery population. The
objective of this study was to evaluate postoperative readmissions after open
(OPEN) and endovascular (ENDO) lower extremity (LE) procedures for
PAD (peripheral artery disease).
Methods: Inpatients with PAD and LE procedures were selected from
the Cerner Health Facts database between October 2008 and December
2010, using International Classification of Diseases-9 Edition-ClinicalMod-
ification diagnosis codes (claudication, rest pain, and ulceration/gangrene)
and procedure codes for LE revascularization (ENDO and OPEN). Read-
mission30 days of discharge was determined. Charlson comorbidity index
was used to adjust for comorbidities, and 2 and multivariable logistic
regression were used to compare patients who received ENDO and OPEN
procedures.
Results:Of 453,257 index admissions, 10,103 patients were identified
with a diagnosis of PAD. Combining PAD with elective LE procedures
during the index admission, 657 and 678 underwent OPEN and ENDO,
respectively. Overall readmission rates or OPEN and ENDO for claudica-
tion, rest pain, and ulceration/gangrene were 9.68% vs 12.50% (P  .29),
14.29% vs 18.60% (P  .38), and 17.9% vs 20% (P  .60); respectively.
Readmission increased by the severity of the diagnosis for both OPEN and
ENDO (P  .0001). Men comprised 59% of the cohort, and readmission
rates were not statistically different by sex (P .25). Race was not associated
with procedure performed (P  .7). After adjustment for age, race, sex,
comorbidities, and procedure, patients with ulceration/gangrene (odds
ratio [OR], 1.7; 95% confidence interval [CI], 1.17-2.41), non-Caucasian
race (OR, 1.5; 95% CI, 1.08-2.19), and increased numbers of comorbidities
(OR, 1.1; 95% CI, 1.01-1.22) were more likely to be readmitted. Diagnoses
at readmission were similar between groups.
Conclusions: Less invasive endovascular procedures were not associ-
ated with decreased readmission rates compared with open surgery. Read-
mission rates for claudicants were unexpectedly high, with an overall rate of
11%. Predictors of readmission included black race and increased severity of
disease. Further examination exploring reasons for readmission are required
to decrease readmission rates in the vascular surgery population.
Midterm Results of Replacement of Synthetic Graft and Arterial Infec-
tion in the Groin With Femoropopliteal Vein
Amanda J. Kravetz, MD. Department of Vascular and Endovascular Sur-
gery, Mayo Clinic, Rochester, Minn. Sponsored by: Manju Kalra, MD,
Rochester, Minn.
Objectives: Infection of synthetic grafts or femoral arteries in the groin
is a challenging problem to treat. Femoropopliteal vein (FPV) is an ideal
conduit, but extensive replacement of infected aortic grafts with FPV has
been associated with significant morbidity. The aim of this study was to
evaluate early and long-term outcome of limited replacement with FPV of
infected femoral arteries/grafts in the groin.
Methods: Data from 37 patients who underwent excision of infected
femoral grafts and replacement with FPV over an 18-year period from 1994
to 2012 were retrospectively analyzed.
Results: Surgical intervention was performed in 41 limbs of 27 men
and 10 women (mean age, 67.5 years) at a median of 2.5 years after the
original synthetic implantation (aortofemoral n 21, femorofemoral n 3,
femorodistal n 5, patch angioplasty n 2) or, on average, 22.2 days after
cardiac catheterization (n  6) and one mycotic aneurysm. Presentation
included draining sinus (n  7), abscess (n  4), persistent fevers (n  6),
and pseudoaneurysm (n  10; intact, 4; ruptured, 6). Twenty-five patients
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